GlassScriptPhysician profile
Harvey M Lisch
NPI 1477588622
$5,338.72
in general payments reported to CMS, 2019-2025
29 companies · $1,060 in 2025
The $1,060 reported for 2025 was more than what 81% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $302 · 2020: $363 · 2021: $421 · 2022: $899 · 2023: $1,296 · 2024: $998 · 2025: $1,060.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,333 · Education: $21.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,332.98 |
| Education | $21.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,203.01 | 2022-2024 | Senza |
| Abbvie INC. | $995.95 | 2021-2025 | |
| Paratek Pharmaceuticals, INC. | $764.46 | 2020-2025 | Nuzyra |
| Stryker Corporation | $366.47 | 2019-2024 | Prostep Mica |
| Horizon Therapeutics Plc | $303.89 | 2019-2023 | Krystexxa |
| Amgen INC. | $303.29 | 2025 | Krystexxa |
| Abbott Laboratories | $298.72 | 2019-2025 | Proclaim |
| Globus Medical, INC. | $173.27 | 2025 | Senza |
| Triad Life Sciences INC. | $136.54 | 2021 | |
| Orthofix Medical, INC. | $106.28 | 2019-2025 | Physio-Stim, Spinal-Stim |
| Medtronic, INC. | $105.11 | 2024 | Intellis Adaptivestim, Vanta Adaptivestim |
| Osteomed LLC | $83.56 | 2020 | |
| Kerecis Limited | $79.65 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Sebela Pharmaceuticals INC. | $62.58 | 2019-2020 | |
| Grt US Holding, INC. | $60.67 | 2020-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $40.48 | 2024 | Qutenza |
| Zyla Life Sciences, INC. | $35.77 | 2020 | |
| Ani Pharmaceuticals, INC. | $29.47 | 2025 | Purified Cortrophin Gel |
| Acera Surgical, INC. | $24.64 | 2024 | Restrata Wound Matrix |
| Reprise Biomedical, INC. | $21.21 | 2025 | Miro3d |
| Assertio Therapeutics, INC. | $20.00 | 2020 | |
| Melinta Therapeutics, LLC | $18.72 | 2020 | |
| Anika Therapeutics, INC. | $18.70 | 2023 | Tactoset |
| Ibsa Pharma INC. | $16.89 | 2023 | Tirosint, Licart |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.89 | 2021 | |
| Smith+Nephew, INC. | $15.46 | 2022 | |
| Tactile Systems Technology INC | $14.63 | 2021 | |
| Hikma Pharmaceuticals USA | $13.05 | 2020 | |
| Dynasplint Systems INC. | $10.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harvey Lisch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.